Robot insulin pumps tested in hospitals to control blood sugar
NCT ID NCT06418880
Summary
This study tested whether an automated insulin delivery system could better control blood sugar in hospitalized adults with type 1 or type 2 diabetes compared to standard insulin injections. 130 participants were randomly assigned to use either the automated system or receive standard injections for up to 10 days. The main goal was to see if the automated system kept blood sugar in a safe range more often and reduced dangerous lows.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Grady Health System (non-CRN)
Atlanta, Georgia, 30322, United States
-
Stanford University School of Medicine
Stanford, California, 94305, United States
-
University of Virginia School of Medicine
Charlottesville, Virginia, 22903, United States
Conditions
Explore the condition pages connected to this study.